Dalan Animal Health, Inc.


Dalan Animal Health is dedicated to providing transformative bioscience solutions supporting a more sustainable future. They develop vaccines that work with nature’s own immune defenses to provide protection from diseases in underserved animal populations such as honeybees and shrimp. Their mission includes accelerating disease control, sustainable food production, and vector-based disease protection across critical sectors like animal health, agriculture, food production, and human health.

Industries

agriculture
agtech
biotechnology
health-care

Nr. of Employees

small (1-50)

Dalan Animal Health, Inc.

University of Georgia, 210 Spring St, Athens, GA 30602, United States


Patents

Use of vitellogenin for defining and testing novel immunogens in insects

US-12145965-B2

View Details

Edible vaccination against microbial pathogens

US-11980660-B2

View Details

Edible vaccination against microbial pathogens

US-10994001-B2

View Details

Products

Inactivated-bacterin vaccine for honeybee brood protection

An orally administered biologic packaged in multi-dose vials intended to prime maternal insects and confer larval protection against brood disease using inactivated bacterial material.

Vaccinated queens distributed via certified producers

Vaccinated maternal organisms (queens) produced by certified producers and sold to beekeepers as a turnkey disease prevention option.

Shrimp vaccine (development-stage)

R&D-stage vaccine program targeting shrimp pathogens relevant to aquaculture (e.g., white spot syndrome and early mortality syndromes) based on adaptation of the platform technology.


Services

Direct sales of multi-dose vaccine vials and facilitation of orders for producers, including minimum order handling and quotes for larger operations.

Consultative support to create vaccination workflows compatible with existing management practices and queen cages, and guidance on administration protocols.

Collaborative field studies and publication support linking vaccination to health outcomes, including safety and efficacy study execution.

Expertise Areas

  • Vaccine development for non-traditional production animals (insects, crustaceans)
  • Translational insect immunology and maternal immune transfer
  • Field safety and efficacy trial design and execution
  • Regulatory compliance for animal biologics (conditional approvals)
  • Show More (3)

Key Technologies

  • Transgenerational immune priming (maternal vaccination)
  • Oral vaccine delivery via feed matrices and secreted glandular transfer
  • Inactivated-bacterin vaccine formulation
  • Field efficacy and safety study methodologies
  • Show More (2)

News & Updates

Recent data reveals alarming colony loss rates averaging over 60%, posing a serious threat to crop pollination, food security, and beekeepers’ livelihoods.

In the February 2025 edition of American Bee Journal, commercial beekeeper Charles Linder shares his perspective on the critical role of innovation in the beekeeping industry, giving special recognition to Dalan’s vaccine.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.